CD8A and non-small cell lung carcinoma: In addition to the findings in CRC, Becht and his colleagues also proved the beneficial effect of high densities of T cells with a Th1 orientation and of cytotoxic CD8+ T cells in non-small cell lung cancer (NSCLC) [3, 4].